LeonaBio

LeonaBio Earnings Yield

The Earnings Yield of LeonaBio (LONA) as of Nov 6, 2026 is -113.92 %. In the previous year, Earnings Yield was -104.57 % — a change of 8.94% (lower).

Earnings Yield

-113.92 %

YoY

8.94%

Last updated:

Earnings Yield of LeonaBio is 2025 -113.92 % . Earnings Yield of LeonaBio was 2024 -104.57 % . It decreases by 8.94% lower compared to the previous year.

The LeonaBio Earnings Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Earnings Yield
Date
Earnings Yield
Jan 1, 2018
-5.50 USD
Jan 1, 2019
-5.57 USD
Jan 1, 2020
-21.53 USD
Jan 1, 2021
-59.17 USD
Jan 1, 2022
-103.16 USD
Jan 1, 2023
-126.93 USD
Jan 1, 2024
-104.57 USD
Jan 1, 2025
-113.92 USD
The LeonaBio Earnings Yield history
YEAREarnings YieldYoY
-113.92 %+8.94%
-104.57 %-17.62%
-126.93 %+23.04%
-103.16 %+74.36%
-59.17 %+174.88%
-21.53 %+286.65%
-5.57 %+1.26%
-5.50 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

LeonaBio Stock analysis

What does LeonaBio do? Athira Pharma, Inc. is a clinical-stage biopharmaceutical company headquartered in Bothell, Washington, that generates revenue by developing small molecules to restore neuronal health and stop neurodegeneration. The firm utilizes its proprietary ATH platform to target and enhance the activity of a vital neuronal growth factor, creating a pipeline of drugs designed to cross the blood brain barrier for the central nervous system or target the peripheral nervous system. This technology underpins the development of ATH-1017, which is specifically intended for the treatment of neurodegenerative disorders with an initial focus on Alzheimer’s disease. The product aims to improve symptoms in cognitively impaired subjects by enhancing neuronal health and promoting regeneration, serving the medical needs of patients suffering from these conditions. LeonaBio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about LeonaBio stock

Earnings Yield of LeonaBio is -113.92 % in 2025.

Earnings Yield of LeonaBio changed from -104.57 % to -113.92 %, representing a 8.94% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings Yield LeonaBio since 2006 – with annual values, charts, and detailed analysis.

Earnings Yield is the inverse of the P/E ratio. It shows the percentage of each dollar invested that was earned by the company. Higher earnings yield indicates better value.

To evaluate Earnings Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Earnings Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Earnings Yield's LeonaBio with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — LeonaBio

All Key Metrics — LeonaBio